Mino Convertible Bond once rose 8%

NightAirdropper · 2026-03-25T05:05:17+00:00

Shanghai Securities News–China Securities Network, March 24, (Reporter Sun Zhong): After the underlying stock was boosted, the Meino convertible bond rose by as much as 8% after the market opened. Benefiting from the weight-loss drug theme taking shape, the issuer Meinohua Co., Ltd.’s stock price has surged sharply in recent days, and on the 24th it was at the daily limit. The company expects that its 2025 net profit attributable to shareholders of the parent company will increase year over year by 49.69% to 84.11%.

NightAirdropper

2026-03-25 05:05:17

Shanghai Securities News, China Securities Journal (Reporter Sun Zhong) — On March 24, supported by the underlying stock, the Mino convertible bond rose as much as 8% after opening.

Benefiting from the fermentation of weight-loss drug themes, issuer MinoPharm’s stock price has recently surged significantly, hitting the daily limit on the 24th. The company expects net profit attributable to shareholders of the parent company in 2025 to increase by 49.69% to 84.11% year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.